GlassScriptPhysician profile
William Michael Dang
NPI 1386701449
$15,970.74
in general payments reported to CMS, 2019-2025
34 companies · $1,901 in 2025
The $1,901 reported for 2025 was more than what 83% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,202 · 2020: $1,719 · 2021: $2,523 · 2022: $2,623 · 2023: $2,155 · 2024: $1,847 · 2025: $1,901.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,904.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,903.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $1,649.76 | 2019-2025 | Camzyos, Eliquis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,624.98 | 2019-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $1,592.26 | 2019-2024 | Brilinta, Farxiga |
| Novartis Pharmaceuticals Corporation | $1,204.07 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $1,146.06 | 2022-2025 | |
| Janssen Pharmaceuticals, INC | $1,019.64 | 2019-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $933.96 | 2019-2025 | Jardiance |
| Abbott Laboratories | $905.15 | 2019-2025 | Xience Skypoint, Jot Dx, Mini Trek |
| Amarin Pharma, INC. | $692.22 | 2019-2023 | |
| Amgen INC. | $622.98 | 2019-2025 | Repatha, Repatha |
| Boston Scientific Corporation | $546.51 | 2019-2025 | Patientcare Link, Emblem Mri S-Icd, Resonate El Icd Vr |
| Merck Sharp & Dohme LLC | $496.14 | 2021-2025 | Verquvo |
| Esperion Therapeutics, INC. | $400.54 | 2020-2024 | Nexletol, Nexlizet |
| Janssen Scientific Affairs, LLC | $367.75 | 2019-2023 | Xarelto |
| Shockwave Medical, INC | $321.97 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $288.78 | 2019 | |
| Teleflex LLC | $253.51 | 2022-2025 | Turnpike |
| Pfizer INC. | $246.59 | 2019-2021 | |
| Regeneron Pharmaceuticals, INC. | $207.62 | 2019 | |
| Penumbra, INC. | $196.82 | 2024 | Ruby Coil |
| Irhythm Technologies, INC. | $157.60 | 2019-2023 | Zio Xt Patch |
| Alnylam Pharmaceuticals INC. | $155.22 | 2021-2025 | Amvuttra |
| Baxter Healthcare | $148.98 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Lexicon Pharmaceuticals, INC. | $148.19 | 2023 | Inpefa |
| Novo Nordisk INC | $136.27 | 2025 | Ozempic |
| Medtronic, INC. | $131.58 | 2025 | Aurora Ev-Icd Mri Surescan |
| Medtronic Vascular, INC. | $130.66 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $88.99 | 2019 | |
| Gilead Sciences, INC. | $45.54 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $29.61 | 2019-2021 | |
| Kiniksa Pharmaceuticals International, Plc | $24.62 | 2024 | Arcalyst |
| Preventice Services, LLC | $21.83 | 2021 | |
| Scpharmaceuticals INC. | $20.88 | 2023 | |
| Cvrx, INC. | $13.46 | 2025 | Barostim Neo System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Dang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.